Quality Investor
MarketsPortfolioEvidenceTestedCompareWatchlistAbout 

Nature's Sunshine Products, Inc.

Rank #5Capital ReturnWatchlistCompare with other stocks

NATR · Nasdaq · Consumer Defensive

Nature's Sunshine Products, Inc. (NATR) — Rank #5 by gross profitability (GP/assets 1.34) · ROE 11.5% · Piotroski F-Score N/A.

As-of 2026-10-30 · CIK 0000275053 · all metrics point-in-time as of the filing date.

About

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.

Show more

The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc.

was founded in 1972 and is headquartered in Lehi, Utah.

Industry
Packaged Foods
Sector
Consumer Defensive
State
UT
Filer Category
Accelerated filerSmaller reporting company
Fiscal Year End
December 31

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

806

Industry

Packaged Foods

Exchange

Nasdaq

11/11

Flags passed

NATR passes 11/11 quality flags

  • PASS
    Gross margin holding
  • PASS
    Dilution within 2%
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Operating margin holding
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Operating leverage expanding · Deferred revenue growing · Sequential beat (rev + EPS)

No data Balance sheet — not counted as a pass.

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
1.34
Return on equity
11.5%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.53
Current ratio
2.60×
Net cash
$82.50M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.2%

Growth

2/2 pass
Revenue growth
5.7%
Piotroski F-Score
N/A
Share dilution
-3.3%

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Does it make money well?

No warning flags · GP/assets 1.34

Gross profitability (GP / assets)

1.34

Primary signal (Novy-Marx).

1st of 12 SIC 2834 peers

Return on equity

11.5%

Gross margin

72.4%

9th of 12 SIC 2834 peers

Revenue growth (YoY)

5.7%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

4.4%

Revenue CAGR (5Y)

4.5%

Earnings CAGR (3Y)

—

FCF CAGR (3Y)

—

Cash Flow Health

Is the cash real?

No warning flags · FCF 48% above net income

Free cash flow

$28.84M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

47.7%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.2%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

No warning flags · net cash $82.50M

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.53

5th of 12 SIC 2834 peers (best = lowest)

Current ratio

2.60×

7th of 12 SIC 2834 peers

Quick ratio

1.40×

Net cash

$82.50M

Cash & equivalents minus total debt.

Piotroski F-Score

N/A

Only 8/9 components determinable.

Valuation

Is the price reasonable?

No warning flags

Capital allocation quality

Composite score

2.3 / 5

Fair
Share count trend(net buybacks)
-3.3%4/5 Strong
Buyback timing
N/AN/A
Dividend growth consistency(non-payer or broken streak)
0 yr3/5 Good
Net debt trajectory
N/A0/5 Weak

Lifecycle Phase History

20202025
Value
Capital Return
Startup

Price History

NATR-20.3% · -4.4% CAGRSPY+82.9% · +12.8% CAGR

View full financial statements →

Source filings on SEC EDGAR: 10-K annual reports · 10-Q quarterly reports